ANDA 210753, held by The J Molner. Diflorasone Diacetate.
As of Nov 15, 2026, ANDA 210753 (Diflorasone Diacetate), held by The J Molner, was first approved by FDA on Jun 12, 2018, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 12, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diflorasone Diacetate0.05% ยท ointment;topical | Diflorasone Diacetate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
